Steroid profiles as potential biomarkers in patients with urogenital tract cancer for diagnostic investigations analyzed by liquid chromatography coupled to mass spectrometry

Journal of Pharmaceutical and Biomedical Analysis

Volumn 73, Issue , 2013, Pages 108-115

  Konieczna, Lucyna ^a   Baczek, Tomasz ^a   Belka, Mariusz ^a   Fel, Anna ^a   Markuszewski, Marcin ^a   Struck, Wiktoria ^a   Markuszewski, Michał ^a   Kaliszan, Roman ^a  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

Author keywords

Biomarkers; Liquid chromatography mass spectrometry; Steroids; Urine sample; Urogenital tract cancer

Indexed keywords

ANDROGEN; CORTICOSTEROID; PROGESTERONE; STEROID;

ALGORITHM; ARTICLE; BLADDER CANCER; CANCER PATIENT; CONTROLLED STUDY; FEMALE; HEALTH STATUS; HUMAN; KIDNEY CANCER; LIQUID CHROMATOGRAPHY; MAJOR CLINICAL STUDY; MALE; MASS SPECTROMETRY; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROSTATE CANCER; STEROID URINE LEVEL; TESTIS CANCER; URINALYSIS; UROGENITAL TRACT CANCER;

ADULT; AGED; ALGORITHMS; ANALYSIS OF VARIANCE; CALIBRATION; CASE-CONTROL STUDIES; CHROMATOGRAPHY, LIQUID; FEMALE; HUMANS; LEAST-SQUARES ANALYSIS; LIMIT OF DETECTION; MALE; MIDDLE AGED; PRINCIPAL COMPONENT ANALYSIS; REFERENCE STANDARDS; REPRODUCIBILITY OF RESULTS; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; STEROIDS; TUMOR MARKERS, BIOLOGICAL; UROGENITAL NEOPLASMS;

EID: 84869502956     PISSN: 07317085     EISSN: 1873264X     Source Type: Journal    
DOI: 10.1016/j.jpba.2012.03.016     Document Type: Article

References (42)

1. Allinson J., Brooks S. Biomarkers in drug development - a CRO perspective. Curr. Sep. 2004, 21:15-19.
2. Henderson B.E., Ross R.K., Malcohlm C., Pike C., Casagrande J.T. Endogenous hormones as a major factor in human cancer. Cancer 1982, 42:3232-3239.
3. Said J. Biomarker discovery in urogenital cancer. Biomarkers 2005, 10:83-86.
4. Hsing A., Reichardt J.K.V., Stańczyk F.Z. Prostate 2002, 52:213-235.
5. Negm R.S., Verma M., Srivastava S. The promise of biomarkers in cancer screening and detection. Trends Mol. Med. A 2002, 8:288-293.
6. Nozaki O. Steroid analysis for medical diagnosis. J. Chromatogr. A 2001, 935:267-278.
7. Penning T.M., Lee S.H., Guitierrez A., Blair I.A. Liquid chromatography-mass spectrometry (LC-MS) of steroid hormone metabolites and its application. J. Steroid Biochem. Mol. Biol. 2010, 121:546-555.
8. Ahs F., Furmark T., Michelgard A., Langstrom B., Appel O.T., Wolf C., Kirschbaum C., Fredrikson M. Hypothalamic blood flow correlates positively with stress-induced cortisol levels in subjects with social anxiety disorder. Psychosom. Med. 2006, 68:859-862.
9. Weber B., Lewicka S., Deuschle M., Colla M., Vecsei P., Heuser I. Increased diurnal plasma concentrations of cortisone in depressed patients. J. Clin. Endocrinol. Metab. 2002, 85:1133-1136.
10. Cleare A.J., Bearn J., Allain T. Contrasting neuroendocrine responses in depression and chronic fatigue syndrome. J. Affect. Disord. 1995, 34:283-289.
11. Palermo M., Shackleton C.H., Mantero F., Stewart P.M. Urinary free cortisone and the assessment of 11 beta-hydroxysteroid dehydrogenase activity in man. Clin. Endocrinol. 1996, 45:605-611.
12. Findings J.W., Raff H. Cushing's syndrome: important issues in diagnosis and management. J. Clin. Endocrinol. Metab. 2006, 91:3746-3753.
13. Nomura S., Fujitaka S., Jinno K. Clinical significance of cortisone and cortisone/cortisol ratio in evaluating children with adrenal diseases. Clin. Chim. Acta 1997, 256:1-11.
14. Quinkler M., Stewart P.M. Hypertension and the cortisol-cortisone shuttle. J. Clin. Endocrinol. Metab. 2003, 88:2384-2392.
15. Lee S.H., Yang Y.J., Kim K.M., Ch Chung B. Altered urinary profiles of polyamines and endogenous steroids in patients with benign cervical disease and cervical cancer. Cancer Lett. 2003, 201:121-131.
16. Missner A., Eliassen A.H., Barbieri R.L., Hankinson S.E. Endogenous estrogen, androgen and progesterone concentrations and breast cancer risk among postmenopausal women. J. Natl. Cancer Inst. 2004, 96:1856-1865.
17. Locke J.A., Guns E.S., Lubik A.A., Adomat H.H., Hendy S.C., Wood C.A., Ettinger S.L., Gleave M.E., Nelson C.C. Androgen levels increase by intratumoral de novo steroidogenesis during progression of castration-resistant cancer. Cancer Res. 2008, 68:6407-6415.
18. Gregory Ch.W., He B., Johnson R.T., Ford O.H., Mohler J.L., French F.S., Wilson E.M. A mechanism for androgen receptor-mediated prostate cancer recurrence after androgen deprivation therapy. Cancer Res. 2001, 61:4315-4319.
19. Shaneyfelt T., Husein R., Bubley G., ChS. Mantzores Hormonal predictors of prostate cancer: a meta-analysis. J. Clin. Oncol. 2000, 18:847-853.
20. Becciolini A., Porcini S., Lanini A., Santoni R., Cionini L. Urinary polyamines in patients with advanced cervical cancer or pelvic cancer recurrence during and after radiotherapy. Acta Oncol. 1992, 31:327-331.
21. Schottenfeld D., Warshner M.E., Sherloc K.S., Zauber A.G., Leder M., Payne R. The epidemiology of testicular cancer in young adults. Am. J. Epidemiol. 1980, 112:232-246.
22. Henderson B.E., Benton B., JinG.J., Yu M., Pike M.C. Risk factors for cancer of the testis in young men. Int. J. Cancer 1979, 23:598-601.
23. Doll R., Muir C., Waterhouse J. Cancer Incidence in Five 56 Countries 1970, vol. 2. Springer-Verlag, Berlin.
24. Waterhouse J., Muir C., Correa P., Powell J. Cancer Incidence in Five Continents 1976, vol. 3. International Agency for Cancer Research, Lyon, France.
25. Johnson L.C. A general theory of bone tumors. Bull. Acad. Med. 1953, 29:164-171.
26. Basaki A., Kirkali Z., Tuzel E., Yorukoglu K., Mungan M.U., Sade M. Prognostic significance of estrogen receptor expression in superficial transitional cell carcinoma of the urinary bladder. Eur. Urol. 2002, 41:342-345.
27. McGrath M., Michaud D.S., De Vivo I. Hormonal and the reproductive factors and the risk of bladder cancer in women. Am. J. Epidemiol. 2006, 163:163-244.
28. Noronha R.F.X., Rao B.R. Sex hormone receptor in localized and advanced transitional cell carcinoma of urinary tract in humans. Urology 1986, 28:401-403.
29. Cantwell M.M., Lacey J.V., Schairer C., Schatzkin A., Michaud D.S. Reproductive factors, exogenous hormone use and bladder cancer risk in a prospective study. Int. J. Cancer 2006, 119:2398-2401.
30. JARC Working Group Hormonal Contraceptives and Post Menopausal Hormonal Therapy. JARC Monographs on the Evaluation of Carcinogenic Risks to Humans 1999, vol. 72:1-492. JARC, Lyon.
31. Wolthers B.G., Kraan G.P.B. Clinical applications of gas chromatography and gas chromatography-mass spectrometry of steroids. J. Chromatogr. A 1999, 843:247-274.
32. Antignac J.P., Brosseaud A., Gaudin-Hirret I., André F., Le Bizec B. Analytical strategies for the direct mass spectrometric analysis of steroid and corticosteroid phase II metabolites. Steroids 2005, 70:205-216.
33. Hauser B., Deschner T., Ch. Boesch Development of a liquid chromatography-tandem mass spectrometry method for the determination of 23 endogenous steroids in small quantities of primate urine. J. Chromatogr. B 2008, 862:100-112.
34. Shackleton C. Clinical steroid mass spectrometry: a 45-year history culminating in HPLC-MS/MS becoming an essential tool for patient diagnosis. J. Steroid Biochem. Mol. Biol. 2010, 121:481-490.
35. Sirén H., Seppanen-Laakso T. Capillary electrophoresis with UV detection and mass spectrometry in method development for profiling metabolites of steroid hormone metabolism. J. Chromatogr. B 2008, 871:375-382.
36. Szymańska E., Markuszewski M.J., Markuszewski M., Kaliszan R. Altered levels of nucleoside metabolite profiles in urogenital tract cancer measured by capillary electrophoresis. J. Pharm. Biomed. Anal. 2010, 53:1305-1312.
37. Konieczna L., Plenis A., Oledzka I., Kowalski P., Baczek T. Optimization of LC method for the determination of testosterone and epitestosterone in urine samples in view of biomedical studies and anti-doping research studies. Talanta 2011, 83:804-814.
38. Plenis A., Konieczna L., Oledzka I., Kowalski P., Baczek T. Simultaneous determination of urinary cortisol, cortisone and corticosterone in parachutists, depressed patients and healthy controls in view of biomedical and pharmacokinetic studies. Mol. BioSyst. 2011, 7:1487-1500.
39. Kennard R.W., Stone L.A. Computer aided design of experiments. Technometrics 1969, 11:137-148.
40. Snee R.D. Validation of regression models: methods and examples. Technometrics 1977, 19:415-428.
41. Daszykowski M., Walczak B., Massart D.L. Representative subset selection. Anal. Chim. Acta 2002, 468:91-103.
42. Detrich K., Demidenko E., Schned A., Zens M.S., Heaney J., Karagas M.R. Parity, early menopause and the incidence of bladder cancer in women: a case-control study and meta-analysis. Eur. J. Cancer 2011, 47:592-599.